Anti-PD-1-Related Pneumonitis during Cancer Immunotherapy

N Engl J Med. 2015 Jul 16;373(3):288-90. doi: 10.1056/NEJMc1505197.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Aged
  • Antibodies, Monoclonal / adverse effects*
  • Female
  • Humans
  • Immunotherapy / adverse effects*
  • Ipilimumab
  • Lung / diagnostic imaging
  • Lung / pathology
  • Male
  • Middle Aged
  • Neoplasms / drug therapy
  • Nivolumab
  • Pneumonia / chemically induced*
  • Pneumonia / diagnostic imaging
  • Programmed Cell Death 1 Receptor / antagonists & inhibitors*
  • Programmed Cell Death 1 Receptor / immunology
  • Radiography

Substances

  • Antibodies, Monoclonal
  • Ipilimumab
  • Programmed Cell Death 1 Receptor
  • Nivolumab